Literature data on the role of FADS3 in breast cancer are still scanty [25], although evidence for an altered fatty acid transport, synthesis and desaturation was recently reported as responsible for breast cancer response to therapy, recurrence and plasticity [26–28]. This evidence concerns the gene FADS3 and breast carcinoma.